← Eichor
Study identifier: NCT02996656 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

Condition: Propionibacterium Infection  ·  Sponsor: Université de Montréal

PhaseNA
Planned participants88
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

INESS Antibiotic Prophylaxis in Orthopedic Guide recommends the use of Cefazolin at induction for all orthopaedic procedure with implantation of internal fixation device. With the increasing rate of identified P. acnes shoulder surgery infection despite the use of recommended skin preparation and preoperative prophylactic antibiotics, a question arises; Is Cefazolin the most effective prophylactic antibiotic for shoulder surgery? The objective of this study is to determine if Ceftriaxone is superior to Cefazolin as a prophylactic antibiotic for skin colonization with P. acnes in primary shoulder surgery

This description comes directly from the study's public registry record.

Talk to the study team

Dominique Rouleau, MD  ·  514-338-2222  ·  dominique_rouleau@yahoo.ca

Karine Tardif  ·  514-338-2222  ·  karinetardif2@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital du Sacré-Cœur de MontréalMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02996656